BioRestorative Therapies (OTCMKTS:BRTX) Stock Price Passes Below 50 Day Moving Average – What’s Next?
by Scott Moore · The Cerbat GemBioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report)’s stock price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $1.16 and traded as low as $1.1101. BioRestorative Therapies shares last traded at $1.15, with a volume of 15,196 shares changing hands.
BioRestorative Therapies Trading Up 3.6%
The firm’s 50-day simple moving average is $1.16 and its 200 day simple moving average is $1.42. The stock has a market cap of $10.21 million, a P/E ratio of -0.78 and a beta of 0.28.
About BioRestorative Therapies
BioRestorative Therapies, Inc (OTCMKTS:BRTX) is a clinical-stage biotechnology company dedicated to developing regenerative medicine therapies for urological, orthopedic and rehabilitative indications. The company’s research focuses on autologous and allogeneic cell therapy platforms designed to repair, regenerate and restore normal tissue function through targeted cell delivery and expansion technologies.
Among its lead programs is BRTX-100, an investigational autologous muscle cell therapy aimed at treating stress urinary incontinence, which is advancing through late-stage clinical studies.